To our knowledge, this is the largest study to evaluate the correlations between 18F-FDG uptake and EGFR mutation status in lung cancer, and the first to investigate the correlation between the 18F-FDG uptake and KRAS mutation status. This evidence concerns the gene KRAS and lung carcinoma.